A Phase 4, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical Cystectomy.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2013
At a glance
- Drugs Alvimopan (Primary)
- Indications Intestinal disorders
- Focus Registrational; Therapeutic Use
- 22 Oct 2013 FDA approval for expanded use of alvimopan after surgery that includes bowel resection with primary anastomosis was primarily supported by data from this trial, according to a Cubist media release.
- 17 Apr 2012 Results have been reported in a Cubist Pharmaceuticals media release.
- 07 Dec 2011 Planned patients number (280) added as reported by M.D. Anderson Cancer Center.